{
  "denotations": [
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 252,
        "end": 282
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 285,
        "end": 289
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 341,
        "end": 351
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 162,
        "end": 165
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "16773681_6",
  "text": "Although pharmacogenetics is a promising field that already contributed to a better understanding of some of the underlying mechanisms of action of drugs used in IBD , the only discovery translated until now into daily practice is the relation between thiopurine S-methyltransferase ( TPMT ) gene polymorphisms and hematological toxicity of thiopurine treatment ."
}
